Materialise NV Sponsored ADR Aktie News

LEUVEN, Belgium, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host an Extraordinary Shareholders' Meeting on Friday, November 14, 2025, at 17:00 CET.

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its plans to pursue an additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares (ADSs) representing ordinary s...

Materialise's Manufacturing segment continues to face headwinds, driven by exposure to areas like prototyping, automotive, and Europe. Materialise's Medical segment continues to perform well, and the Software segment appears set to rebound in coming quarters. Despite macro challenges, Materialise remains cash flow positive and has a strong net cash position.

Materialise NV (NASDAQ:MTLS ) Q3 2025 Earnings Call October 28, 2025 8:30 AM EDT Company Participants Brigitte de Vet-Veithen - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Harriet Fried - Lippert/Heilshorn & Associates, Inc. Troy Jensen - Cantor Fitzgerald & Co., Research Division Presentation Operator Good day, and welcome to the Q3 2025 Materiali...

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a global leader in 3D-printed medical devices and software and a pioneer in additive manufacturing software and services, today announced its financial results for the third quarter ended September 30, 2025. Highlights – Third Quarter 2025 Total consolidated revenue increased 2.2% to 66,259 kEUR compared to the second quarter of 20...

Materialise is rated BUY with a $10 target, offering over 60% upside potential using a DCF with conservative assumptions. MTLS's Medical segment drives growth, offsetting industrial weakness; management focuses on mass personalization in healthcare and cost control. Industrial segment faces cyclical headwinds, but MTLS is shifting toward aerospace/defense and exiting less profitable operations ...

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the third quarter ended September 30, 2025 on Tuesday, October 28, 2025 at 6:30 a.m. ET/11:30 a.m. CET. Senior management will hold a conference call to discuss the third quart...

Materialise's Q2 results were weak due to European automotive headwinds and macro uncertainty. Materialise's Medical segment continues to thrive, and its Software business is nearly done transitioning to a recurring revenue model. Medical segment strength justifies a higher valuation, but the Manufacturing business must stabilize before the stock can meaningfully re-rate.